Life Extension Magazine®
There once was a time when the U.S. Government stated that there was no relationship between dietary fat intake and artery disease. Not only did the government publish their proclamation, but enforced it at gunpoint. The basis for censoring this dietary information was an edict by the FDA that made it illegal to even imply that fats and oils had a relationship to diseases of the heart and arteries. According to the FDA, to make any statement about fat consumption and heart attack risk constituted “misbranding,” a serious criminal offense. An excerpt of the FDA’s misguided prohibition statement appears on the next page. How times have changed! On May 27, 2003, The White House urged health agencies of government to encourage Americans to increase their consumption of foods rich in omega-3 fatty acids and decrease their intake of trans fatty acids. The release issued by the Executive Office of The President stated: “Health researchers have found that Americans can significantly reduce the risk of heart disease with a modest change in their diets. The government should make this life-saving information as widely available as possible.” A basis for The White House’s initiative are new guidelines by the American Heart Association that recommends consuming cold-water fish at least twice a week and other oils and food sources high in omega-3 fatty acids. The Office of The President also cited the “growing body of scientific evidence, both experimental and epidemiological, that suggests that consumption of trans fatty acids increases the risk of coronary heart disease.”
The political battle over what Americans eat For nearly two decades, the FDA protected the economic interests of companies selling high fat and high cholesterol foods by making it illegal to promote healthy diet as a way of preventing heart disease. Heart attack rates were three times higher in the 1950’s than in the 1990’s. The FDA’s censorship of healthy dietary information caused millions of Americans to unnecessarily succumb to cardiovascular and other diseases. For instance, it was long ago established that consumption of cold-water fish reduced the risk of heart attack.1 In fact, just two to three servings of fish a week can protect against many diseases including, arthritis, stroke, certain cancers and a host of inflammatory-related disorders.2-9 When scientists sought to discover what components of fish were responsible for preventing heart attacks, they found that the oil played a critical role. Cold-water fish oil is high in omega-3 fatty acids that function in multiple ways to reduce cardiovascular disease risk.10 Based on the published scientific evidence about fish oil, a lawsuit was filed in 1994 by Durk Pearson and Sandy Shaw against the FDA seeking to force the agency to allow the following health claim: "Consumption of omega-3 fatty acids may reduce the risk of coronary heart disease.” The FDA rejected this one sentence claim and a multi-year litigation battle erupted. In their lawsuit, Durk and Sandy pointed out that consumers would benefit by learning of the value of fish oil in protecting against heart disease. On a legal basis, it was argued that the FDA lacked the constitutional authority to ban this truthful and non-misleading health claim. The FDA contended that this health claim was not adequately backed by scientific studies and that the agency had the legal discretion to ban these kinds of health claims. Seven years of expensive litigation ensued as the FDA asserted that it had the sole authority to dictate what Americans could read on the label of fish oil supplements. After an onslaught of irrefutable scientific evidence was presented, including articles published in the most prestigious scientific journals in the world, the FDA capitulated and said it would permit the following claim: “Consumption of omega-3 fatty acids may reduce the risk of coronary heart disease. FDA evaluated the data and determined that although there is scientific evidence supporting the claim, the evidence is not conclusive.” The White House’s new position on heart disease The Life Extension Foundation believes The White House is understating the number of lives that could be saved. According to an article published in The Lancet,3 men who consume the most trans fatty acids have twice the risk of developing heart disease compared to their counterparts who consumed the least. The American Heart Association recently published a study of 11,323 heart attack patients showing that those who took a 1000 mg fish oil supplement every day were 45% less likely to be dead at the end of 3.5 years. The White House is not emphasizing the enormity of human suffering that would be eliminated if Americans were better educated about what foods they should eat. While it is true that 500,000 Americans die from heart disease annually, there are about one million people who suffer heart attacks each year. The economic costs of open-heart surgeries, cardiac rehabilitation, cardiac drugs and emergency room visits is bankrupting the health care system of this nation. Aggressive government action to better educate consumers about healthier diets could dramatically postpone the date when Medicare becomes insolvent. Approximately 300,000 of the annual heart attack fatalities are of the “sudden death” variety. The omega-3 fatty acids (found in cold water fish oils) are particularly protective against these “sudden death” heart attacks. Studies show that as few as two fish meals a week reduce heart attack risk by half.11 If all Americans regularly took fish oil supplements or ate about two cold-water fishmeals a week, it could prevent about 150,000 sudden death heart attacks a year. During the seven years it took to litigate the fish oil health claim against the FDA, over one million preventable sudden death heart attacks were suffered by American citizens.
FDA reform urgently needed The effects of fish oil on cardiovascular health have been consistently unambiguous, i.e., those who eat cold-water fish have fewer heart attacks. The FDA took this easy-to-understand fact and turned it into a complex legal morass that took seven years to resolve. There are many promising lifesaving drugs bogged down in the FDA’s regulatory quagmire. The safety and efficacy of these drugs is far more difficult to comprehend than ascertaining whether fish oil is beneficial. Yet the FDA still retains absolute authority to decide if and when these drugs will ever be approved. Meanwhile, those whose lives could be saved by these yet-to-be-approved therapies perish every day. The chilling effects of censorship What is genocidal about the FDA being wrong, however, is their police-state power to suppress opposition. Those who don’t agree with the FDA are subject to criminal indictment, forfeiture and imprisonment. This kind of draconian authority has a chilling effect on the dissemination and implementation of new scientific principles. Under today’s totalitarian system, creative solutions to life-threatening diseases are stifled not only because of direct FDA actions, but also by the fear of becoming the next victim of a FDA witch-hunt. | ||||||||
The White House Urges Greater Omega-3 Consumption | |||
It took seven years of intensive litigation to force the FDA to recognize the value of fish oil. There are too many new compounds that may prevent and treat disease to allow a central bureaucracy with a proven track record of failure to continue making life and death decisions for the American public. Until recently, it was a criminal offense to promote omega-3 fatty acids to reduce cardiovascular disease risk. Now the White House is encouraging the FDA and other Federal agencies to do more to enlighten consumers about the benefits of omega-3 fatty acids and the dangers of trans fatty acids. The invariable question is, will future Presidential administrations encourage Americans to follow health concepts that the FDA is suppressing today? Are scientific pioneers sitting in American prisons whose original ideas will later show to be medically correct? A free market solution Consumers who want government “protection” could insist on only using FDA-approved products, while those who want to be more aggressive could experiment with products that would specifically state on their labels: “Not Approved By The FDA.” This free choice system would release the creative energies of physician-scientists whose new ideas are presently silenced by fear of FDA persecution. We believe the result of this greater freedom would be a marvelous medical renaissance. The FDA survives because of an apathetic American public who has grown so used to government incompetence that they feel little can be done to change it. The Life Extension Foundation, on the other hand, has proven that positive changes can occur at the Federal level if enough citizens speak up. As a member of The Life Extension Foundation, you belong to an elite group who possess the knowledge to differentiate scientific authenticity from the political hyperbole long espoused by the FDA. For longer life, William Faloon.
| |||
References | |||
1. Garcia-Closas R, et al. Fish consumption, omega-3 fatty acids and the Mediterranean diet. Eur J Clin Nutr 1993 Sep;47 Suppl 1:S85-90. 2. Iso H, et al. Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA 2001 Jan 17;285(3):304-12. 3. Konard RJ, et al. Eicosapentaenoic acid (C20:5) augments glucose-induced insulin secretion from beta-TC3 insulinoma cells. Pancreas 1996 Oct;13(3):253-8. 4. Tsuda H; et al. Demonstration of organotropic effects of chemopreventive agents in multiorgan carcinogenesis models. IARC Sci Publ (FRANCE) 1996, (139) p143-50. 5. Lai PB, et al. Cell cycle arrest and induction of apoptosis in pancreatic cancer cells exposed to eicosapentaenoic acid in vitro. Br J Cancer 1996 Nov;74(9):1375-83. 6. Das UN. Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease. Prostaglandins Leukot Essent Fatty Acids. 1995 Jun;52(6):387-91. 7. Thorngren M, et al. Effects of 11-week increases in dietary eicosapentaenoic acid on bleeding time, lipids and platelet aggregation. Lancet (England) Nov 28 1981, 2 (8257) p1190-3. 8. Okuda Y, et al. Long-term effects of eicosapentaenoic acid on diabetic peripheral neuropathy and serum lipids in patients with type II diabetes mellitus. Journal of Diabetes and its Complications (USA), 1996, Sep-Oct;10(5):280-7. 9. Sinclair AJ, et al. Marine lipids: overview news insights and lipid composition of Lyprinol. Allerg Immunol (Paris) 2000 Sep;32(7):261-71. 10. Yam D, et al. The effect of omega-3 fatty acids on risk factors for cardiovascular diseases. Harefuah 2001 Dec;140(12):1156-8, 1230. 11. Connor WE. n-3 Fatty acids from fish and fish oil: panacea or nostrum? Am J Clin Nutr 2001 Oct;74(4):415-6. 12. Dyerberg J, Bang HO. A hypothesis on the development of acute myocardial infarction in Greenlanders. Scand J Clin Lab Invest Suppl 1982;161:7-13. 13. www.healthy.net/asp/templates/news.asp?Id=5713. 14. de Roos NM, et al. Replacement of dietary saturated fatty acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial function in healthy men and women. Arterioscler Thromb Vasc Biol 2001 Jul;21(7):1233-7. 15. Oomen CM, et al. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet 2001 Mar 10;357(9258):746-51. |